Antisocial Personality Disorder

Tips for Success for the Individual power point Presentation & Written Paper:

1. Times New Roman/ 12-point font
   Medications are also implemented in the treatment of ADHD for adults and children 6 years old and older. The ultimate goal of behavioral therapy is to reinforce positive behaviors or simply just learn them, and to eliminate as much as possible unwanted problematic behavior (CDC, 2020).
2. No bullet points. Essay format only.
3. SSRIs and SNRIs:
   Examples: Sertraline (Zoloft), Paroxetine (Paxil), Venlafaxine (Effexor), Duloxetine (Cymbalta)
   Dosage: Varies by medication; titration may be needed.
   Pharmacokinetics: SSRIs have a long half-life, SNRIs vary.
4. Double spaced
   In the domain of pharmacotherapy for PTSD, Prazosin emerges as another noteworthy agent.
   Prazosin, typified by the brand Minipress, is typically initiated at a 1 mg dose administered at
   bedtime and may be gradually titrated to attain the desired therapeutic outcome.
5. All sections covered in your PowerPoint Presentation must be covered in the paper.
6. Paragraphs: Must have a minimum of 5 sentences to be considered a full paragraph
   There are no specific medications for antisocial personality disorder, however, medications are prescribed to help manage some of the symptoms. The three main classes of medications that are prescribed are SSRIs, antipsychotics, and mood stabilizers. SSRIs are used to help treat depression, antipsychotics are used to treat aggression and impulsive behaviors, and mood stabilizers are used to treat mood swings.
7. Do not use artificial intelligence (AI, ChatGPT etc…) or any other outside source to write your paper. If you do, you will receive a 0 for the assignment.
8. Use Microsoft Editor in Microsoft Word to check your word count, spelling, and grammar.
9. Your entire paper must be in APA format and include a references list, and a cover page.
10. Your paragraphs must have in-text citations. See handout available on Canvas.
    The goal of treatment for DID focuses on the stability and safety of the patient rather than trauma. Treatment is divided into 3 phases. Phases are not linear and sometimes overlap, and each may take several years to complete. Co-occurring disorders may also require treatment for patients with DID. (Note the missing citation.)
11. The page limit for this paper is 3-4 pages not including your cover page or references list. Points will be taken off if you go above the page limit.

Individual power point Presentation
Clinical faculty will assign topic for the psychiatric disease (Antisocial personality disorder) with psychopharmacology presentation/paper to each student in the beginning of the semester and assign the date for each student presentation. Students will submit individual paper and a corresponding power point presentation to the dropdown menu. Students will present their power point during post-conference on a day which has been assigned by the faculty.

1. Pathophysiology of the selected psychiatric disease 2 points
2. Psychopharmacology for treatment of the selected disease (provide examples of the medications, their classifications, and recommended dosages) 3 points
   • Pharmacokinetics
   • Pharmacodynamics
   • Pharmacotherapeutics
   • Major side effects and their prevention, particularly, how will you identify and prevent Neuroleptic Malignant Syndrome, tardive dyskinesia, and extrapyramidal symptoms (EPS) if you are discussing antipsychotic medication.
3. Drug-drugs-interactions and therapeutic blood levels if required 1 point
4. Nursing Considerations 2 point
5. Clients’ Teaching 1 point
   APA format, correct spelling and grammar 1 point

Total (10 points =100%)

The paper not power point should be written in no more than 3 pages format, excluding front cover page and a reference page.
Please submit a power point presentation and individual paper in the drop down menu.

Rubric
Individual Presentation and Written Paper
Individual Presentation and Written Paper
Criteria Ratings Pts
This criterion is linked to a Learning Outcome Pathophysiology of the selected psychiatric disease 2 pts
Full Marks 0 pts
No Marks
2 pts

This criterion is linked to a Learning OutcomePsychopharmacology for treatment of the selected disease (provide examples of the medications, their classifications, and recommended dosages)
Pharmacokinetics
Pharmacodynamics
Pharmacotherapeutics
Major side effects and their prevention, particularly, how will you identify and prevent Neuroleptic Malignant Syndrome, tardive dyskinesia, and extrapyramidal symptoms (EPS) if you are discussing antipsychotic medication. 3 pts
Full Marks 0 pts
No Marks
3 pts

This criterion is linked to a Learning OutcomeDrug-drugs-interactions and therapeutic blood levels if required 1 pts
Full Marks 0 pts
No Marks
1 pts

This criterion is linked to a Learning OutcomeNursing Considerations 2 pts
Full Marks 0 pts
No Marks
2 pts

This criterion is linked to a Learning OutcomeClients’ Teaching 1 pts
Full Marks 0 pts
No Marks
1 pts

This criterion is linked to a Learning OutcomeAPA format, correct spelling and grammar 1 pts
Full Marks 0 pts
No Marks
1 pts

Total Points: 10

Definition and Epidemiology

Antisocial personality disorder is a pattern of socially irresponsible, exploitative, and guiltless behavior that reflects a general disregard for the rights of others. These individuals exploit and manipulate others for personal gain and are unconcerned with obeying the law. They have difficulty sustaining consistent employment and developing stable relationships. This personality disorder has been extensively studied and has been included in all editions of the Diagnostic and Statistical Manual of Mental Disorders. In the United States, prevalence is estimated to be about 3% in the general population, but in prison populations, the prevalence is 50% or higher (Hatchett, 2015). It is more common in men than in women and in the lower socioeconomic classes, especially among highly mobile inhabitants of impoverished urban areas. The DSM-5-TR currently identifies antisocial personality and psychopathy as synonymous terms, but recent research reveals that these are better understood as distinct disorders (Hatchett, 2015; Thompson et al., 2014). Substance use disorder is commonly identified as a comorbid disorder.
NOTE: The clinical picture, predisposing factors, nursing diagnoses, and interventions for care of clients with antisocial personality disorder are presented later in this chapter.

For antisocial personality disorder, pharmacotherapy is generally not recommended unless it is being used to treat a comorbid condition although anticonvulsants may be of benefit to treat aggressive behavior, especially in the presence of abnormal electroencephalogram (EEG) waveforms (Boland & Verduin, 2022).

Caution must be used when prescribing medications outside the structured setting because of the high risk for substance use disorders in this population. In addition, benzodiazepines should be avoided, particularly in patients with BPD, because of the increased risk for disinhibition, which may increase acting out and self-harm behaviors (Black, 2021).

More info on this disease on this website
https://www.ncbi.nlm.nih.gov/books/NBK546673/

1. Pathophysiology of Antisocial Personality Disorder:
   o Antisocial Personality Disorder (ASPD) is characterized by a pervasive pattern of disregard for and violation of the rights of others. The exact pathophysiology is not fully understood, but it likely involves a combination of genetic, environmental, and neurobiological factors.
   o Research suggests that abnormalities in brain structure and function, particularly in areas responsible for impulse control, decision-making, and empathy, may contribute to the development of ASPD.
2. Psychopharmacology for Treatment of Antisocial Personality Disorder:
   o There are no specific medications approved for the treatment of ASPD itself. However, pharmacotherapy may be used to target comorbid conditions such as depression, anxiety, or impulsivity.
   o Examples of medications that may be prescribed include:
    Selective serotonin reuptake inhibitors (SSRIs) for symptoms of depression and anxiety.
    Mood stabilizers such as lithium or anticonvulsants for impulsivity and aggression.
    Atypical antipsychotics for aggressive or impulsive behaviors.
   o Dosages would depend on the specific medication, the severity of symptoms, and individual patient factors. Dosages should be determined and monitored by a qualified healthcare provider.
3. Pharmacokinetics, Pharmacodynamics, and Pharmacotherapeutics:
   o These aspects would vary depending on the specific medications used, so it’s important to refer to prescribing information for each drug.
   o Pharmacokinetics involves how the body processes the medication, including absorption, distribution, metabolism, and elimination.
   o Pharmacodynamics refers to the effects of the medication on the body, including its mechanism of action and therapeutic effects.
   o Pharmacotherapeutics involves the clinical use of medications to treat symptoms and improve outcomes.
4. Major Side Effects and Prevention:
   o Common side effects of medications used to treat symptoms of ASPD may include drowsiness, dizziness, weight gain, and sexual dysfunction.
   o To prevent serious side effects such as Neuroleptic Malignant Syndrome (NMS), tardive dyskinesia, and extrapyramidal symptoms (EPS) associated with antipsychotic medications, it’s important to monitor patients regularly for signs and symptoms, adjust dosages as needed, and consider alternative medications if side effects occur.
5. Drug-Drug Interactions and Therapeutic Blood Levels:
   o Potential drug interactions should be assessed before prescribing medications for ASPD, especially if the patient is taking other psychotropic medications or drugs metabolized through similar pathways.
   o Therapeutic blood levels are typically not relevant for medications used to treat symptoms of ASPD, as they are often prescribed based on symptom management rather than maintaining specific blood levels.
6. Nursing Considerations:
   o Nurses play a crucial role in monitoring patients for adverse effects of medications, educating patients about their medications and potential side effects, and supporting patients in adhering to their treatment plans.
7. Clients’ Teaching:
   o Patients should be educated about the purpose of their medications, potential side effects, and the importance of adherence to their treatment plan.
   o Emphasize the need for regular follow-up appointments with healthcare providers to monitor medication effectiveness and adjust treatment as needed.
   o Encourage patients to report any concerning symptoms or side effects promptly.
   This overview provides a broad understanding of the pharmacological and nursing considerations for treating symptoms associated with Antisocial Personality Disorder. However, it’s important to individualize treatment approaches based on each patient’s unique presentation and needs.